The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ordan Mark S since 2015.
This trader's CIK number is 1208541.
At the time of last reporting, Ordan Mark S was the Chief Executive Officer of Pediatrix Medical Group, Inc.. (stock ticker symbol MD).
Also see all insider trading activities at Pediatrix Medical Group, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | MD | 0 | $0 | 23,000 | $515,430 | 0 | $0 |
| 2024 | MD | 0 | $0 | 27,600 | $423,660 | 0 | $0 |
| 2023 | MD | 0 | $0 | 33,000 | $437,580 | 0 | $0 |
| 2022 | MD | 0 | $0 | 44,332 | $684,928 | 0 | $0 |
| 2021 | MD | 0 | $0 | 95,000 | $3,333,550 | 95,000 | $1,676,749 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | WPG | 25,000 | $332,500 | 0 | $0 | 0 | $0 |
1. Pediatrix Medical Group, Inc. (MD)
2. Washington Prime Group Inc. (WPG)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-12-15 | MD | Sale | 23,000 | 22.41 | 515,430 |
| 2024-11-13 | MD | Sale | 27,600 | 15.35 | 423,660 |
| 2023-05-25 | MD | Sale | 33,000 | 13.26 | 437,580 |
| 2022-11-21 | MD | Sale | 22,166 | 15.45 | 342,464 |
| 2022-11-21 | MD | Sale | 22,166 | 15.45 | 342,464 |
| 2021-08-30 | MD | Sale | 95,000 | 35.09 | 3,333,550 |
| 2021-08-30 | MD | Option Ex | 95,000 | 17.65 | 1,676,749 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-06-11 | WPG | Buy | 25,000 | 13.30 | 332,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ordan Mark S (Chief Executive Officer of Pediatrix Medical Group, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.